New York: Neuralink, the brain-computer interface company founded by Elon Musk, has reportedly raised $600 million in fresh funding, pushing its valuation to a staggering $9 billion, according to a report from Semafor citing sources familiar with the deal.
The significant capital injection underscores investor confidence in Neuralink’s ambitious mission to develop implantable brain chips designed to revolutionize neurological treatment and human-computer interaction. The company has yet to issue an official comment in response to Reuters’ request for clarification.
Previously valued at approximately $5 billion in 2023 based on private share transactions described to Reuters, Neuralink has rapidly attracted attention from top-tier investors. A notable $280 million round was previously led by Peter Thiel’s Founders Fund. In April, Bloomberg News reported the company’s intent to raise around $500 million, a figure now exceeded by the latest funding.
Also Read | Residents Begin Recovery After Deadly Chemical Plant Explosion in China
Neuralink’s flagship device is currently undergoing trials aimed at assisting individuals with spinal cord injuries. According to the company, its first human trial participant has successfully used the implant to control a laptop cursor, play video games, browse the internet, and post on social media—all via thought alone.
The company recently received a “breakthrough device” designation from the U.S. Food and Drug Administration (FDA), a label intended to expedite the development and review of innovative medical technologies that offer significant advantages over existing options.
Also Read | India Enforces Rigorous Testing on CCTV Equipment Amid Rising Security Fears
Musk has long spoken of transformative goals for Neuralink. He envisions a future where both disabled and healthy individuals could visit local clinics for swift, chip-implantation procedures aimed at treating conditions such as obesity, depression, autism, and schizophrenia. Beyond medical applications, Musk has also discussed possibilities ranging from telepathy to seamless internet access through direct brain interaction.
As Neuralink continues to draw both capital and controversy, its bold vision places it at the forefront of the emerging neurotechnology sector.
